BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

QUVA PHARMA, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

QUVA PHARMA, INC.

via PRIME POLICY GROUP

4th Quarter (Oct 1 - Dec 31) · 2023Posted Jan 18, 2024Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: QUVA PHARMA, INC.
Description: 503B outsourcing facility
Location: Texas · United States of America

Registrant

Firm: PRIME POLICY GROUP
Description: Government relations
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Legislation and regulation impacting outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act
LobbyistsEMILY AUSTEN KATZ
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.